Workshop with EnVast in Lugano
The engaging and highly interactive program, led by Prof. Marco Valgimigli, combined theoretical lectures, hands-on sessions, clinical case discussions, and interactive debates, all aimed at exploring the challenges of coronary thrombectomy and the use of enVast technology.
NeVa Clot Interaction Workshop Barcelona
From March 12-14, 2025, Vesalio hosted an exceptional group of physicians and stroke care experts at our NeVa Clot Interaction Workshop in Barcelona.
NeVa at SFNR2025
This week at SFNR, Prof. Dr. Sébastien Soize from CHU de Reims shared the inspiring journey of NeVa, highlighting its early trials, the CLEAR study, and emphasizing its exceptional first-pass success rates along with its strong safety profile.
Case in Germany: Success with Armadillo
Armadillo case from UKE Hamburg-Eppendorf. Thank you for sharing your insights, Dr. Vincent Geest, Lucas Kath (MTRA), and Dr. Fabian Alexander Flottmann.
What sets NeVa apart in thrombectomy?
What sets NeVa apart in thrombectomy? Experts discuss its radial force and Drop Zone technology, designed to improve the efficiency of clot capture and removal in complex stroke cases.
Dr. Carlo Penzo’s opinions on EnVast
A special thanks to Dr. Carlo Penzo from the University Hospital of Ferrara for his valuable insights on the EnVast mechanical thrombectomy device.
Case in Sweden: the success of Armadillo
Thanks to Dr. Hozan Radhi for his extraordinary testimonial on the use of the Armadillo neurovascular access catheter in Sweden.
Case in Italy: the first success of Armadillo
We are pleased to present the first success of Armadillo in Italy! Thanks to Dr. Chegai for sharing his valuable insights.
Waiting for iCure Stroke 2025 with an interesting case from the 2022 event!
This case was broadcast live during the iCureStroke 2022 meeting.
Full of surprises, the case began with the patient presenting with signs of hemianopsia and significant restriction in DWI of the PCA territory.
CE mark approved for Armadillo!
Our partner Q’Apel Medical, a privately-owned medical device company focused on revolutionising neurovascular interventions, has received CE mark certification for its Armadillo SelectFlex™ Neurovascular Access System.
